C the Signs
C the Signs is a cancer prediction system that can identify patients at risk of cancer at the earliest and most curable stage of the disease. In under 30 seconds, C the Signs can rapidly identify…
C the Signs
C the Signs is a cancer prediction system that can identify patients at risk of cancer at the earliest and most curable stage of the disease. In under 30 seconds, C the Signs can rapidly identify…
TL;DR
What they do: AI clinical decision support that identifies patients at risk of cancer earlier in primary care
Regulatory status: MHRA Class I medical device
Primary integrations: EMIS and SystmOne
Reported scale: >400,000 risk assessments; 50,000–70,000 cancers detected (company-reported)
Notable investors: MMC Ventures; Khosla Ventures; CancerX (listed among investors)
Company Overview
Problem Domain
Early cancer detection in primary care
Industry
Hospitals and Health Care
Funding Track Record
Crunchbase lists a total of six funding rounds and seven investors (additional rounds not individually detailed in evidence)
Investor Signal
“MMC Ventures; Khosla Ventures; CancerX Startup Accelerator listed among investors”
Founders
What we do
Related Companies
| Company |
|---|
 |
 |
 |
 |
 |